Scarica l'app Stockscreener
15.05
0.20%
-0.03
Dopo l'orario di chiusura:
14.91
-0.14
-0.93%
Panoramica
Notizia
Cronologia dei prezzi
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$15.08
Aprire:
$15.03
Volume 24 ore:
9,609
Relative Volume:
0.09
Capitalizzazione di mercato:
$209.08M
Reddito:
$6.67M
Utile/perdita netta:
$-47.55M
Rapporto P/E:
-10.03
EPS:
-1.5
Flusso di cassa netto:
$-17.44M
1 W Prestazione:
+15.24%
1M Prestazione:
+20.40%
6M Prestazione:
+2,843%
1 anno Prestazione:
+2,843%
Intervallo 1D:
$14.81
$15.32
Intervallo di 1 settimana:
$13.16
$15.39
Portata 52W:
$9.81
$21.40
Crescent Biopharma Inc Stock (CBIO) Company Profile
Nome
Crescent Biopharma Inc
Settore
Industria
Telefono
617-430-5595
Indirizzo
300 FIFTH AVENUE, WALTHAM, CA
Confronta CBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBIO
Crescent Biopharma Inc
|
15.05 | 253.08M | 6.67M | -47.55M | -17.44M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | Jefferies | Buy |
| 2025-08-11 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-14 | Iniziato | Wedbush | Outperform |
| 2025-06-25 | Iniziato | Stifel | Buy |
| 2025-03-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-11 | Iniziato | Noble Capital Markets | Outperform |
| 2024-07-26 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-22 | Iniziato | CapitalOne | Overweight |
| 2021-11-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-04-29 | Ripresa | Stephens | Overweight |
| 2021-02-10 | Iniziato | Piper Sandler | Overweight |
| 2020-05-21 | Iniziato | Raymond James | Outperform |
| 2019-11-14 | Iniziato | ROTH Capital | Buy |
| 2019-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2019-08-05 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-01-04 | Iniziato | Oppenheimer | Outperform |
| 2018-12-18 | Iniziato | H.C. Wainwright | Buy |
| 2018-02-12 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Reiterato | Chardan Capital Markets | Buy |
| 2017-12-08 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Iniziato | Chardan Capital Markets | Buy |
| 2017-06-06 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-07-26 | Iniziato | SunTrust | Buy |
| 2016-06-30 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-17 | Reiterato | Stifel | Buy |
Mostra tutto
Crescent Biopharma Inc Borsa (CBIO) Ultime notizie
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Crescent Biopharma Advances Cancer Therapy Pipeline - MSN
MSN Money - MSN
Is Crescent Biopharma Inc. (GKO0) stock protected from inflationJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Will Crescent Biopharma Inc. (GKO0) stock recover faster than industryJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickExit Point & AI Powered Buy/Sell Recommendations - newser.com
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stock2025 Top Decliners & Daily Entry Point Alerts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of “Buy” from Analysts - Defense World
Crescent Biopharma (Nasdaq: CBIO) Approves 451,448-Share Inducement Options at $13.02 - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating - Defense World
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetrationEntry Point & Long-Term Safe Return Strategies - newser.com
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stock2025 Price Targets & Community Consensus Picks - newser.com
Can Crescent Biopharma Inc. (GKO0) stock beat analyst consensusBond Market & AI Forecasted Entry and Exit Points - newser.com
Crescent Biopharma to present preclinical data from CR-001 - MSN
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Crescent Biopharma, Inc. (C68.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Crescent Biopharma, Inc. (C68.F) Interactive Stock Chart - Yahoo! Finance Canada
Crescent Biopharma: Q3 Earnings Snapshot - theheraldreview.com
Crescent Biopharma Inc expected to post a loss of $2.02 a shareEarnings Preview - TradingView
Crescent Biopharma, Inc. (C68.F) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
[S-8] CRESCENT BIOPHARMA, INC. Employee Benefit Plan Registration | CBIO SEC FilingForm S-8 - Stock Titan
CRESCENT BIOPHARMA, INC. SEC 10-Q Report - TradingView
Crescent Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[8-K] CRESCENT BIOPHARMA, INC. Reports Material Event | CBIO SEC FilingForm 8-K - Stock Titan
Crescent Biopharma Inc Azioni (CBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):